Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia

Published:2013-09-20 Issue:12 Volume:3 Page:1416-1429
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discovery

Author:

Pemovska Tea,Kontro Mika,Yadav Bhagwan,Edgren Henrik,Eldfors Samuli,Szwajda Agnieszka,Almusa Henrikki,Bespalov Maxim M.,Ellonen Pekka,Elonen Erkki,Gjertsen Bjørn T.,Karjalainen Riikka,Kulesskiy Evgeny,Lagström Sonja,Lehto Anna,Lepistö Maija,Lundán Tuija,Majumder Muntasir Mamun,Marti Jesus M. Lopez,Mattila Pirkko,Murumägi Astrid,Mustjoki Satu,Palva Aino,Parsons Alun,Pirttinen Tero,Rämet Maria E.,Suvela Minna,Turunen Laura,Västrik Imre,Wolf Maija,Knowles Jonathan,Aittokallio Tero,Heckman Caroline A.,Porkka Kimmo,Kallioniemi Olli,Wennerberg Krister

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The cellular hierarchy of acute myeloid leukemia informs personalized treatment;2024-07-24

2. Acute lymphoblastic leukaemia;Nature Reviews Disease Primers;2024-06-13

3. Evaluation of BH3 mimetics as a combination therapy with irradiation in head and neck squamous cell carcinoma;Biomedicine & Pharmacotherapy;2024-06

4. Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia;Cell Reports Medicine;2024-05

5. A phenotypic screening approach to target p60AmotL2-expressing invasive cancer cells;Journal of Experimental & Clinical Cancer Research;2024-04-09